Title : Multitarget effects of quercetin in leukemia.

Pub. Date : 2014 Dec

PMID : 25293876






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 P39 cell treatment with a combination of quercetin and selective inhibitors of ERK1/2 and/or JNK (PD184352 or SP600125, respectively), significantly decreased cells in G1 phase, this treatment, however, did not change the apoptotic cell number. 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide mitogen-activated protein kinase 8 Homo sapiens